Breaking News Instant updates and real-time market news.

BTC

Bitcoin

/

+

, $BTC

Bitcoin

/

+

10:55
03/29/23
03/29
10:55
03/29/23
10:55

SEC charges crypto trading platform Beaxy for operating unregistered exchange

The Securities and Exchange Commission charged the crypto asset trading platform beaxy.com and its executives for failing to register as a national securities exchange, broker, and clearing agency. The SEC also charged the founder of the platform, Artak Hamazaspyan, and a company he controlled, Beaxy Digital, Ltd., with raising $8M in an unregistered offering of the Beaxy token and alleged that Hamazaspyan misappropriated at least $900,000 for personal use, including gambling. Finally, the SEC charged market makers operating on the Beaxy Platform as unregistered dealers. According to the SEC's complaint, since October 2019, Nicholas Murphy and Randolph Bay Abbott, through the company they managed, Windy Inc., maintained and provided the Beaxy Platform as a web-based trading platform that facilitated buying and selling of crypto assets that were offered and sold as securities. The complaint alleges that Windy, through the Beaxy Platform, violated the Securities Exchange Act of 1934 because it: Brought together the orders for securities of multiple buyers and sellers using established, non-discretionary methods under which such orders interacted, and the buyers and sellers entering such orders agreed to the terms of a trade, and thus should have registered as an exchange; Acted as an intermediary in making payments and deliveries upon matching sell and buy orders and maintained custody of customer assets, and thus should have registered as a clearing agency; and Was regularly engaged in the business of effecting transactions for the account of others in crypto assets that were offered and sold as securities, and thus should have registered as a broker. Reference Link

BTC

Bitcoin

/

+

$BTC

Bitcoin

/

+

BITCOIN

Bitcoin

/

+

OTHER BREAKING NEWS FROM THE FLY

Initiation
Baxter assumed with an Equal Weight at Morgan Stanley » 06:48
05/30/23
05/30
06:48
05/30/23
06:48
BAX

Baxter

$41.29 /

-0.055 (-0.13%)

Morgan Stanley assumed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:48

Get Free Trial

ShowHide Related Items >><<
BAX Baxter
$41.29 /

-0.055 (-0.13%)

BAX Baxter
$41.29 /

-0.055 (-0.13%)

05/01/23 Barclays
Baxter price target raised to $58 from $54 at Barclays
04/28/23 Stifel
Baxter price target raised to $54 from $45 at Stifel
04/28/23 Deutsche Bank
Baxter price target raised to $50 from $40 at Deutsche Bank
04/28/23 TD Cowen
Baxter price target raised to $50 from $45 at TD Cowen
BAX Baxter
$41.29 /

-0.055 (-0.13%)

BAX Baxter
$41.29 /

-0.055 (-0.13%)

BAX Baxter
$41.29 /

-0.055 (-0.13%)

BAX Baxter
$41.29 /

-0.055 (-0.13%)

Initiation
Becton Dickinson assumed with an Overweight at Morgan Stanley » 06:48
05/30/23
05/30
06:48
05/30/23
06:48
BDX

Becton Dickinson

$241.13 /

-0.49 (-0.20%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:48

Get Free Trial

ShowHide Related Items >><<
BDX Becton Dickinson
$241.13 /

-0.49 (-0.20%)

BDX Becton Dickinson
$241.13 /

-0.49 (-0.20%)

05/08/23 Barclays
Becton Dickinson price target raised to $284 from $282 at Barclays
05/05/23 Piper Sandler
Becton Dickinson upgraded to Overweight after pullback at Piper Sandler
05/05/23 Piper Sandler
Becton Dickinson upgraded to Overweight from Neutral at Piper Sandler
04/12/23 KeyBanc
Becton Dickinson upgraded to Overweight from Sector Weight at KeyBanc
BDX Becton Dickinson
$241.13 /

-0.49 (-0.20%)

BDX Becton Dickinson
$241.13 /

-0.49 (-0.20%)

Hot Stocks
Team regains NYSE compliance » 06:47
05/30/23
05/30
06:47
05/30/23
06:47
TISI

Team

$8.10 /

+1.08 (+15.38%)

Team announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:47

Get Free Trial

ShowHide Related Items >><<
TISI Team
$8.10 /

+1.08 (+15.38%)

Hot Stocks
Golden Minerals to effect 1-for-25 reverse stock split » 06:46
05/30/23
05/30
06:46
05/30/23
06:46
AUMN

Golden Minerals

/

+

Golden Minerals announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:46

Get Free Trial

ShowHide Related Items >><<
AUMN Golden Minerals
/

+

AUMN Golden Minerals
/

+

03/24/23 Alliance Global Partners
Golden Minerals price target lowered to 80c from $1.10 at Alliance Global
08/04/22 H.C. Wainwright
Golden Minerals price target lowered to 60c from $1 at H.C. Wainwright
Recommendations
PayPal recent weakness should be bought, says Mizuho » 06:45
05/30/23
05/30
06:45
05/30/23
06:45
PYPL

PayPal

$60.22 /

+0.835 (+1.41%)

Mizuho analyst Dan Dolev…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:45

Get Free Trial

ShowHide Related Items >><<
PYPL PayPal
$60.22 /

+0.835 (+1.41%)

PYPL PayPal
$60.22 /

+0.835 (+1.41%)

05/22/23 Bernstein
PayPal price target lowered to $70 from $85 at Bernstein
05/19/23 Morgan Stanley
Morgan Stanley says proposed 1099-K legislation 'incremental positive' for Block
05/12/23 Exane BNP Paribas
PayPal downgraded to Neutral from Outperform at Exane BNP Paribas
05/11/23 Barclays
PayPal price target lowered to $92 from $108 at Barclays
PYPL PayPal
$60.22 /

+0.835 (+1.41%)

PYPL PayPal
$60.22 /

+0.835 (+1.41%)

PYPL PayPal
$60.22 /

+0.835 (+1.41%)

PYPL PayPal
$60.22 /

+0.835 (+1.41%)

Recommendations
Lantheus selloff on competitor approval overdone, says Mizuho » 06:42
05/30/23
05/30
06:42
05/30/23
06:42
LNTH

Lantheus

$91.06 /

-6.855 (-7.00%)

Mizuho views…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:42

Get Free Trial

ShowHide Related Items >><<
LNTH Lantheus
$91.06 /

-6.855 (-7.00%)

LNTH Lantheus
$91.06 /

-6.855 (-7.00%)

05/05/23 SVB Securities
Lantheus price target raised to $127 from $120 at SVB Securities
05/05/23 Truist
Lantheus price target raised to $125 from $115 at Truist
05/05/23 JMP Securities
Lantheus price target raised to $130 from $120 at JMP Securities
05/05/23 Mizuho
Lantheus price target raised to $125 from $115 at Mizuho
LNTH Lantheus
$91.06 /

-6.855 (-7.00%)

LNTH Lantheus
$91.06 /

-6.855 (-7.00%)

Recommendations
Omega Healthcare price target lowered to $31 from $32 at Mizuho » 06:39
05/30/23
05/30
06:39
05/30/23
06:39
OHI

Omega Healthcare

$28.34 /

+0.25 (+0.89%)

Mizuho analyst Vikram…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:39

Get Free Trial

ShowHide Related Items >><<
OHI Omega Healthcare
$28.34 /

+0.25 (+0.89%)

OHI Omega Healthcare
$28.34 /

+0.25 (+0.89%)

05/03/23 Stifel
Omega Healthcare price target lowered to $33 from $36 at Stifel
04/19/23 Wells Fargo
Omega Healthcare initiated with an Overweight at Wells Fargo
01/13/23 Baird
Omega Healthcare price target lowered to $29 from $32 at Baird
01/09/23 Credit Suisse
Omega Healthcare downgraded to Underperform from Neutral at Credit Suisse
OHI Omega Healthcare
$28.34 /

+0.25 (+0.89%)

Recommendations
Ventas price target lowered to $53 from $60 at Mizuho » 06:39
05/30/23
05/30
06:39
05/30/23
06:39
VTR

Ventas

$42.87 /

+0.045 (+0.11%)

Mizuho analyst Vikram…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:39

Get Free Trial

ShowHide Related Items >><<
VTR Ventas
$42.87 /

+0.045 (+0.11%)

VTR Ventas
$42.87 /

+0.045 (+0.11%)

04/25/23 Barclays
Ventas price target lowered to $55 from $57 at Barclays
04/19/23 Wells Fargo
Wells Fargo starts Ventas with Overweight on senior housing growth
04/19/23 Wells Fargo
Ventas initiated with an Overweight at Wells Fargo
04/12/23 Credit Suisse
Ventas price target lowered to $50 from $51 at Credit Suisse
VTR Ventas
$42.87 /

+0.045 (+0.11%)

Recommendations
Welltower price target lowered to $86 from $91 at Mizuho » 06:38
05/30/23
05/30
06:38
05/30/23
06:38
WELL

Welltower

$73.54 /

-0.07 (-0.10%)

Mizuho lowered the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:38

Get Free Trial

ShowHide Related Items >><<
WELL Welltower
$73.54 /

-0.07 (-0.10%)

WELL Welltower
$73.54 /

-0.07 (-0.10%)

05/24/23 Deutsche Bank
Deutsche ups target on 'must-own' Welltower to $84 from $81
05/16/23 RBC Capital
Welltower price target raised to $87 from $82 at RBC Capital
04/19/23 Wells Fargo
Wells Fargo starts Ventas with Overweight on senior housing growth
04/19/23 Wells Fargo
Welltower initiated with an Overweight at Wells Fargo
WELL Welltower
$73.54 /

-0.07 (-0.10%)

WELL Welltower
$73.54 /

-0.07 (-0.10%)

WELL Welltower
$73.54 /

-0.07 (-0.10%)

WELL Welltower
$73.54 /

-0.07 (-0.10%)

Recommendations
Xcel Energy price target lowered to $69 from $72 at Mizuho » 06:36
05/30/23
05/30
06:36
05/30/23
06:36
XEL

Xcel Energy

$64.34 /

+0.06 (+0.09%)

Mizuho analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:36

Get Free Trial

ShowHide Related Items >><<
XEL Xcel Energy
$64.34 /

+0.06 (+0.09%)

XEL Xcel Energy
$64.34 /

+0.06 (+0.09%)

04/05/23 BMO Capital
Xcel Energy price target lowered to $73 from $74 at BMO Capital
03/17/23 Mizuho
Xcel Energy price target lowered to $72 from $75 at Mizuho
12/14/22 Wells Fargo
Xcel Energy price target raised to $76 from $69 at Wells Fargo
11/21/22 Credit Suisse
Xcel Energy downgraded to Neutral from Outperform at Credit Suisse
XEL Xcel Energy
$64.34 /

+0.06 (+0.09%)

XEL Xcel Energy
$64.34 /

+0.06 (+0.09%)

Recommendations
C4 Therapeutics price target lowered to $10, transferred at Evercore ISI » 06:35
05/30/23
05/30
06:35
05/30/23
06:35
CCCC

C4 Therapeutics

$3.08 /

-0.015 (-0.48%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:35

Get Free Trial

ShowHide Related Items >><<
CCCC C4 Therapeutics
$3.08 /

-0.015 (-0.48%)

CCCC C4 Therapeutics
$3.08 /

-0.015 (-0.48%)

05/08/23 H.C. Wainwright
C4 Therapeutics price target lowered to $25 from $35 at H.C. Wainwright
03/28/23 BofA
C4 Therapeutics price target lowered to $5 from $11 at BofA
02/24/23 Credit Suisse
Credit Suisse ups C4 Therapeutics to Neutral on 'dramatically' improved outlook
02/24/23 Credit Suisse
C4 Therapeutics upgraded to Neutral from Underperform at Credit Suisse
CCCC C4 Therapeutics
$3.08 /

-0.015 (-0.48%)

CCCC C4 Therapeutics
$3.08 /

-0.015 (-0.48%)

Recommendations
Salesforce price target raised to $250 from $225 at Wells Fargo » 06:33
05/30/23
05/30
06:33
05/30/23
06:33
CRM

Salesforce

$215.46 /

+5.58 (+2.66%)

Wells Fargo raised the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:33

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$215.46 /

+5.58 (+2.66%)

CRM Salesforce
$215.46 /

+5.58 (+2.66%)

06:13 Today Canaccord
Salesforce price target raised to $230 from $215 at Canaccord
05/26/23 Evercore ISI
Workday price target raised to $240 from $225 at Evercore ISI
05/26/23 Citi
Salesforce price target raised to $229 from $210 at Citi
05/25/23 Wedbush
Salesforce price target raised to $230 from $220 at Wedbush
CRM Salesforce
$215.46 /

+5.58 (+2.66%)

CRM Salesforce
$215.46 /

+5.58 (+2.66%)

CRM Salesforce
$215.46 /

+5.58 (+2.66%)

CRM Salesforce
$215.46 /

+5.58 (+2.66%)

Upgrade
BofA upgrades ChargePoint to Buy with shares at all-time lows » 06:33
05/30/23
05/30
06:33
05/30/23
06:33
CHPT

ChargePoint

$8.50 /

+0.175 (+2.10%)

BofA analyst Alex Vrabel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:33

Get Free Trial

ShowHide Related Items >><<
CHPT ChargePoint
$8.50 /

+0.175 (+2.10%)

CHPT ChargePoint
$8.50 /

+0.175 (+2.10%)

06:05 Today BofA
ChargePoint upgraded to Buy from Neutral at BofA
05/08/23 B. Riley
ChargePoint price target lowered to $12 from $18 at B. Riley
05/02/23 Guggenheim
ChargePoint initiated with a Neutral at Guggenheim
04/25/23 Stifel
Wallbox price target lowered to $9 from $14 at Stifel
CHPT ChargePoint
$8.50 /

+0.175 (+2.10%)

CHPT ChargePoint
$8.50 /

+0.175 (+2.10%)

CHPT ChargePoint
$8.50 /

+0.175 (+2.10%)

CHPT ChargePoint
$8.50 /

+0.175 (+2.10%)

Earnings
Skyline Champion reports Q4 EPS $1.00, consensus 93c » 06:32
05/30/23
05/30
06:32
05/30/23
06:32
SKY

Skyline Champion

$64.49 /

+0.435 (+0.68%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:32

Get Free Trial

ShowHide Related Items >><<
SKY Skyline Champion
$64.49 /

+0.435 (+0.68%)

02/08/23 Craig-Hallum
Skyline Champion price target raised to $78 from $65 at Craig-Hallum
02/08/23 RBC Capital
Skyline Champion price target raised to $65 from $54 at RBC Capital
12/30/22 Wedbush
Wedbush favors four homebuilding stocks heading into 2023
12/14/22 Barclays
Skyline Champion downgraded to Equal Weight from Overweight at Barclays
SKY Skyline Champion
$64.49 /

+0.435 (+0.68%)

SKY Skyline Champion
$64.49 /

+0.435 (+0.68%)

Hot Stocks
SpringsWorks Therapeutics says Phase 2 nirogacestat trial fully enrolled » 06:31
05/30/23
05/30
06:31
05/30/23
06:31
SWTX

SpringsWorks Therapeutics

$27.79 /

-2.18 (-7.27%)

SpringWorks Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:31

Get Free Trial

ShowHide Related Items >><<
SWTX SpringsWorks Therapeutics
$27.79 /

-2.18 (-7.27%)

SWTX SpringsWorks Therapeutics
$27.79 /

-2.18 (-7.27%)

04/28/23 Barclays
SpringsWorks Therapeutics price target lowered to $41 from $55 at Barclays
03/07/23 H.C. Wainwright
SpringsWorks Therapeutics price target raised to $105 from $99 at H.C. Wainwright
01/02/23 Barclays
Barclays views GSK acquisition interest as positive for oncology stocks
12/01/22 BofA
SpringsWorks Therapeutics initiated with a Buy, $45 price target at BofA
SWTX SpringsWorks Therapeutics
$27.79 /

-2.18 (-7.27%)

SWTX SpringsWorks Therapeutics
$27.79 /

-2.18 (-7.27%)

Recommendations
ServiceNow price target raised to $665 from $586 at Bernstein » 06:30
05/30/23
05/30
06:30
05/30/23
06:30
NOW

ServiceNow

$537.41 /

+5.65 (+1.06%)

Bernstein analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:30

Get Free Trial

ShowHide Related Items >><<
NOW ServiceNow
$537.41 /

+5.65 (+1.06%)

NOW ServiceNow
$537.41 /

+5.65 (+1.06%)

05/26/23 Evercore ISI
Workday price target raised to $240 from $225 at Evercore ISI
05/18/23 Barclays
ServiceNow price target raised to $559 from $551 at Barclays
05/17/23 Goldman Sachs
Goldman Sachs increasingly positive on ServiceNow after Analyst Day
05/17/23 Piper Sandler
Piper says 'don't split hairs,' buy ServiceNow shares
NOW ServiceNow
$537.41 /

+5.65 (+1.06%)

NOW ServiceNow
$537.41 /

+5.65 (+1.06%)

NOW ServiceNow
$537.41 /

+5.65 (+1.06%)

Upgrade
SVB upgrades Elevation Oncology to Outperform on Claudin18.2 ADC SYSA180 data » 06:27
05/30/23
05/30
06:27
05/30/23
06:27
ELEV

Elevation Oncology

$5.00 /

+1.99 (+66.11%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:27

Get Free Trial

ShowHide Related Items >><<
ELEV Elevation Oncology
$5.00 /

+1.99 (+66.11%)

ELEV Elevation Oncology
$5.00 /

+1.99 (+66.11%)

06:04 Today SVB Securities
Elevation Oncology upgraded to Outperform from Market Perform at SVB Securities
11/10/22 JPMorgan
Elevation downgraded to Underweight on more difficult path at JPMorgan
11/10/22 JPMorgan
Elevation Oncology downgraded to Underweight from Neutral at JPMorgan
11/07/22 SVB Securities
Elevation Oncology downgraded to Market Perform from Outperform at SVB Securities
ELEV Elevation Oncology
$5.00 /

+1.99 (+66.11%)

Upgrade
Canadian Western Bank upgraded to Outperform from Sector Perform at RBC Capital » 06:26
05/30/23
05/30
06:26
05/30/23
06:26
CBWBF

Canadian Western Bank

$16.94 /

-1.01 (-5.63%)

RBC Capital analyst Darko…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:26

Get Free Trial

ShowHide Related Items >><<
CBWBF Canadian Western Bank
$16.94 /

-1.01 (-5.63%)

05:26 Today Barclays
Canadian Western Bank price target lowered to C$26 from C$27 at Barclays
05/16/23 CIBC
Canadian Western Bank price target lowered to C$28 from C$30 at CIBC
05/09/23 Barclays
Canadian Western Bank price target lowered to C$27 from C$29 at Barclays
03/03/23 TD Securities
Canadian Western Bank price target lowered to C$33 from C$34 at TD Securities
Initiation
Viridian Therapeutics initiated with an Outperform at RBC Capital » 06:25
05/30/23
05/30
06:25
05/30/23
06:25
VRDN

Viridian Therapeutics

$23.73 /

-0.095 (-0.40%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:25

Get Free Trial

ShowHide Related Items >><<
VRDN Viridian Therapeutics
$23.73 /

-0.095 (-0.40%)

VRDN Viridian Therapeutics
$23.73 /

-0.095 (-0.40%)

05/10/23 Oppenheimer
Viridian Therapeutics price target lowered to $40 from $45 at Oppenheimer
05/10/23 JMP Securities
Viridian Therapeutics price target lowered to $44 from $46 at JMP Securities
04/17/23 Wells Fargo
Viridian Therapeutics initiated with an Overweight at Wells Fargo
03/29/23 Stifel
Viridian Therapeutics initiated with a Buy at Stifel
VRDN Viridian Therapeutics
$23.73 /

-0.095 (-0.40%)

  • 17
    Aug
VRDN Viridian Therapeutics
$23.73 /

-0.095 (-0.40%)

Initiation
Kenvue initiated with an Outperform at RBC Capital » 06:24
05/30/23
05/30
06:24
05/30/23
06:24
KVUE

Kenvue

$26.29 /

-0.01 (-0.04%)

, JNJ

Johnson & Johnson

$154.34 /

-0.0698 (-0.05%)

RBC Capital initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:24

Get Free Trial

ShowHide Related Items >><<
KVUE Kenvue
$26.29 /

-0.01 (-0.04%)

JNJ Johnson & Johnson
$154.34 /

-0.0698 (-0.05%)

KVUE Kenvue
$26.29 /

-0.01 (-0.04%)

06:21 Today BofA
Kenvue initiated with a Buy at BofA
05:13 Today Exane BNP Paribas
Kenvue initiated with a Neutral at Exane BNP Paribas
05:06 Today Citi
Johnson & Johnson resumed with a Buy at Citi
05:02 Today JPMorgan
JPMorgan starts Kenvue with Overweight on 'resilient growth'
JNJ Johnson & Johnson
$154.34 /

-0.0698 (-0.05%)

05:06 Today Citi
Johnson & Johnson resumed with a Buy at Citi
05:02 Today JPMorgan
JPMorgan starts Kenvue with Overweight on 'resilient growth'
04:32 Today Goldman Sachs
Kenvue initiated with a Neutral at Goldman Sachs
05/24/23 Piper Sandler
Cooper Companies price target raised to $430 from $375 at Piper Sandler
JNJ Johnson & Johnson
$154.34 /

-0.0698 (-0.05%)

  • 04
    May
KVUE Kenvue
$26.29 /

-0.01 (-0.04%)

JNJ Johnson & Johnson
$154.34 /

-0.0698 (-0.05%)

KVUE Kenvue
$26.29 /

-0.01 (-0.04%)

JNJ Johnson & Johnson
$154.34 /

-0.0698 (-0.05%)

KVUE Kenvue
$26.29 /

-0.01 (-0.04%)

JNJ Johnson & Johnson
$154.34 /

-0.0698 (-0.05%)

Initiation
Kenvue initiated with a Buy at BofA » 06:21
05/30/23
05/30
06:21
05/30/23
06:21
KVUE

Kenvue

$26.29 /

-0.01 (-0.04%)

BofA analyst Anna Lizzul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:21

Get Free Trial

ShowHide Related Items >><<
KVUE Kenvue
$26.29 /

-0.01 (-0.04%)

KVUE Kenvue
$26.29 /

-0.01 (-0.04%)

05:13 Today Exane BNP Paribas
Kenvue initiated with a Neutral at Exane BNP Paribas
05:06 Today Citi
Johnson & Johnson resumed with a Buy at Citi
05:02 Today JPMorgan
JPMorgan starts Kenvue with Overweight on 'resilient growth'
04:53 Today Citi
Kenvue initiated with a Neutral at Citi
  • 04
    May
KVUE Kenvue
$26.29 /

-0.01 (-0.04%)

KVUE Kenvue
$26.29 /

-0.01 (-0.04%)

KVUE Kenvue
$26.29 /

-0.01 (-0.04%)

Initiation
Steris initiated with an Equal Weight at Morgan Stanley » 06:19
05/30/23
05/30
06:19
05/30/23
06:19
STE

Steris

$200.50 /

-0.735 (-0.37%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:19

Get Free Trial

ShowHide Related Items >><<
STE Steris
$200.50 /

-0.735 (-0.37%)

STE Steris
$200.50 /

-0.735 (-0.37%)

05/12/23 Piper Sandler
Steris price target raised to $200 from $197 at Piper Sandler
05/12/23 KeyBanc
Steris price target raised to $235 from $210 at KeyBanc
04/14/23 Piper Sandler
Steris downgraded to Neutral from Overweight at Piper Sandler
02/15/23 JMP Securities
Steris price target lowered to $240 from $250 at JMP Securities
STE Steris
$200.50 /

-0.735 (-0.37%)

STE Steris
$200.50 /

-0.735 (-0.37%)

STE Steris
$200.50 /

-0.735 (-0.37%)

Initiation
Cooper Companies initiated with an Equal Weight at Morgan Stanley » 06:18
05/30/23
05/30
06:18
05/30/23
06:18
COO

Cooper Companies

$369.30 /

-2.325 (-0.63%)

Morgan Stanley initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:18

Get Free Trial

ShowHide Related Items >><<
COO Cooper Companies
$369.30 /

-2.325 (-0.63%)

05/24/23 Piper Sandler
Cooper Companies price target raised to $430 from $375 at Piper Sandler
05/16/23 Stifel
Cooper Companies price target raised to $420 from $380 at Stifel
05/15/23 Wells Fargo
Cooper Companies price target raised to $430 from $355 at Wells Fargo
04/18/23 Mizuho
Cooper Companies price target raised to $400 from $390 at Mizuho
COO Cooper Companies
$369.30 /

-2.325 (-0.63%)

COO Cooper Companies
$369.30 /

-2.325 (-0.63%)

COO Cooper Companies
$369.30 /

-2.325 (-0.63%)

Periodicals
Tesla CEO Musk's private jet lands in Beijing, Reuters reports » 06:16
05/30/23
05/30
06:16
05/30/23
06:16
TSLA

Tesla

$193.14 /

+8.715 (+4.73%)

A private jet used by…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:16

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$193.14 /

+8.715 (+4.73%)

TSLA Tesla
$193.14 /

+8.715 (+4.73%)

06:06 Today Barclays
Tesla must address model concentration, says Barclays
05/23/23 Oppenheimer
Shares may move higher near-term as Tesla outperforms peers, says Oppenheimer
05/18/23 Wedbush
Wedbush says Tesla/Musk strategy feels solid as investors focus on price wars
05/17/23 Wedbush
Potential advertising campaign 'a major positive' for Tesla, says Wedbush
TSLA Tesla
$193.14 /

+8.715 (+4.73%)

TSLA Tesla
$193.14 /

+8.715 (+4.73%)

TSLA Tesla
$193.14 /

+8.715 (+4.73%)

TSLA Tesla
$193.14 /

+8.715 (+4.73%)

Periodicals
CEO Olczak charting path for Philip Morris to become an ESG stock, FT reports » 06:16
05/30/23
05/30
06:16
05/30/23
06:16
PM

Philip Morris

$90.86 /

+0.09 (+0.10%)

Philip Morris' CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:16

Get Free Trial

ShowHide Related Items >><<
PM Philip Morris
$90.86 /

+0.09 (+0.10%)

PM Philip Morris
$90.86 /

+0.09 (+0.10%)

04/13/23 Stifel
Philip Morris resumed with a Buy at Stifel
03/30/23 JPMorgan
Philip Morris upgraded to Overweight from Neutral at JPMorgan
03/01/23 UBS
UBS upgrades Philip Morris to Buy into heated tobacco launches
03/01/23 UBS
Philip Morris upgraded to Buy from Neutral at UBS
PM Philip Morris
$90.86 /

+0.09 (+0.10%)

PM Philip Morris
$90.86 /

+0.09 (+0.10%)

PM Philip Morris
$90.86 /

+0.09 (+0.10%)

PM Philip Morris
$90.86 /

+0.09 (+0.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.